Need for Transparency and Reliable Evidence in Emergency Use Authorizations for COVID-19 Therapies

This Viewpoint discusses potential problems with the US Food and Drug Administration ’s emergency use authorization document allowing hydroxychloroquine and chloroquine for the treatment of coronavirus disease 2019 (COVID-19).
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research